<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">MOG </span>
   <span class="font31">ADEM </span>
   <span class="font23">patients </span>
   <span class="font22">disseminated </span>
   <span class="font22">antibody </span>
   <span class="font21">children </span>
   <span class="font20">demyelinating </span>
   <span class="font19">acute </span>
   <span class="font19">{border-style </span>
   <span class="font18">encephalomyelitis </span>
   <span class="font18">Neurol </span>
   <span class="font18">clinical </span>
   <span class="font18">px;} </span>
   <span class="font17">#ffffff;} </span>
   <span class="font17">disorders </span>
   <span class="font17">lesions </span>
   <span class="font16">antibodies </span>
   <span class="font16">diagnosis </span>
   <span class="font16">ADEM, </span>
   <span class="font16">oligodendrocyte </span>
   <span class="font16">disease </span>
   <span class="font16">glycoprotein </span>
   <span class="font15">associated </span>
   <span class="font15">myelin </span>
   <span class="font15">neurologic </span>
   <span class="font15">cases </span>
   <span class="font15">matter </span>
   <span class="font15">multiple </span>
   <span class="font15">rates </span>
   <span class="font14">Acute </span>
   <span class="font14">CSF </span>
   <span class="font14">Clinical </span>
   <span class="font14">antibody-associated </span>
   <span class="font14">higher </span>
   <span class="font14">include </span>
   <span class="font14">increased </span>
   <span class="font14">presence </span>
   <span class="font14">relapse </span>
   <span class="font14">white </span>
   <span class="font14">Neurology </span>
   <span class="font14">disorders, </span>
   <span class="font14">relapsing </span>
   <span class="font14">reported </span>
   <span class="font13">antibody-positive </span>
   <span class="font13">brain </span>
   <span class="font13">disease, </span>
   <span class="font13">monophasic </span>
   <span class="font13">multiphasic </span>
   <span class="font13">px; </span>
   <span class="font13">{font-family </span>
   <span class="font13">CNS </span>
   <span class="font13">Mult </span>
   <span class="font13">Scler </span>
   <span class="font13">diagnostic </span>
   <span class="font13">font-size </span>
   <span class="font13">pediatric </span>
   <span class="font13">presentation </span>
   <span class="font13">sclerosis </span>
   <span class="font13">spectrum </span>
   <span class="font13">study </span>
   <span class="font13">therapeutic </span>
   <span class="font12">ADEM. </span>
   <span class="font12">United </span>
   <span class="font12">double; </span>
   <span class="font12">encephalopathy </span>
   <span class="font12">features </span>
   <span class="font12">identified </span>
   <span class="font12">inflammatory </span>
   <span class="font12">positivity </span>
   <span class="font12">present </span>
   <span class="font12">studies </span>
   <span class="font12">testing </span>
   <span class="font12">treatment </span>
   <span class="font12">Dale </span>
   <span class="font12">MRI </span>
   <span class="font12">MS, </span>
   <span class="font12">NMOSD, </span>
   <span class="font12">States </span>
   <span class="font12">acquired </span>
   <span class="font12">age </span>
   <span class="font12">anti-MOG </span>
   <span class="font12">behavioral </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">central </span>
   <span class="font12">criteria </span>
   <span class="font12">data </span>
   <span class="font12">diagnosed </span>
   <span class="font12">differential </span>
   <span class="font12">findings </span>
   <span class="font12">including </span>
   <span class="font12">initial </span>
   <span class="font12">intrathecal </span>
   <span class="font12">long-term </span>
   <span class="font12">nervous </span>
   <span class="font12">neuroimaging </span>
   <span class="font12">occur </span>
   <span class="font12">relapses </span>
   <span class="font12">solid; </span>
   <span class="font12">steroid </span>
   <span class="font12">virus, </span>
   <span class="font12">younger </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">Antibodies </span>
   <span class="font11">Department </span>
   <span class="font11">Hacohen </span>
   <span class="font11">Interestingly, </span>
   <span class="font11">Med </span>
   <span class="font11">Neurology, </span>
   <span class="font11">Neuropediatrics </span>
   <span class="font11">ON, </span>
   <span class="font11">Table </span>
   <span class="font11">[], </span>
   <span class="font11">additional </span>
   <span class="font11">analysis </span>
   <span class="font11">appears </span>
   <span class="font11">article </span>
   <span class="font11">autoimmune </span>
   <span class="font11">bold </span>
   <span class="font11">cell </span>
   <span class="font11">consistent </span>
   <span class="font11">courier; </span>
   <span class="font11">course </span>
   <span class="font11">demyelination </span>
   <span class="font11">em; </span>
   <span class="font11">encephalomyelitis: </span>
   <span class="font11">event </span>
   <span class="font11">forms </span>
   <span class="font11">frequently </span>
   <span class="font11">indicate </span>
   <span class="font11">involving </span>
   <span class="font11">large </span>
   <span class="font11">likely </span>
   <span class="font11">neuroimmunologic </span>
   <span class="font11">paediatric </span>
   <span class="font11">polyphasic </span>
   <span class="font11">poorly </span>
   <span class="font11">present, </span>
   <span class="font11">primary </span>
   <span class="font11">pt;} </span>
   <span class="font11">regard </span>
   <span class="font11">responses </span>
   <span class="font11">risk </span>
   <span class="font11">serum </span>
   <span class="font11">severe </span>
   <span class="font11">specific </span>
   <span class="font11">syndrome </span>
   <span class="font11">systemic </span>
  </p>
 </body>
</html>
